PINK1 anticorps (N-Term)
Aperçu rapide pour PINK1 anticorps (N-Term) (ABIN363489)
Antigène
Voir toutes PINK1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-50, N-Term
-
Specificité
- Reacts with human, mouse and rat PINK1
-
Purification
- Antigen affinity purified
-
Immunogène
- An N-terminal region synthetic peptide made to the human PINK1 protein sequence (between residues 1-50).
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
WB(1:500) -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Tris-citrate, phosphate, ( pH 7-8) buffer, Sodium azide 0.1 %
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 4°C. Do not freeze.
-
-
- PINK1 (PTEN Induced Putative Kinase 1 (PINK1))
-
Autre désignation
- Pink1
-
Sujet
- Phosphatase and Tensin Homolog (PTEN) dephosphorylates lipids.Malfunctions in this contribute to many human cancers.PTEN induced putative kinase 1 (Pink1) was first discovered when researching the PTEN signaling pathway, thus Pink1 is also involved in many human cancers.It is found in the mitochondria and its homozygous C-terminus mutation has beenimplicated in the early development of Parkinson's disease.
-
ID gène
- 65018
-
Pathways
- Autophagy
Antigène
-